Neuroma, Acoustic
A benign SCHWANNOMA of the eighth cranial nerve (VESTIBULOCOCHLEAR NERVE), mostly arising from the vestibular branch (VESTIBULAR NERVE) during the fifth or sixth decade of life. Clinical manifestations include HEARING LOSS; HEADACHE; VERTIGO; TINNITUS; and FACIAL PAIN. Bilateral acoustic neuromas are associated with NEUROFIBROMATOSIS 2. (From Adams et al., Principles of Neurology, 6th ed, p673)
Subtype terms (1)
More specific conditions that are subtypes of Neuroma, Acoustic in the MeSH hierarchy.
- Neurofibromatosis 2
19 drugs (12 approved, 7 experimental)
Drugs by status
Phase 4 trials (1)
Phase 2 trials (14)
Phase 1 trials (4)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (1)
Organization Involved with Phase 2 Indications (25)
- Takeda
- AstraZeneca
- Genentech
- Novartis
- Auris Medical
- Betta Pharmaceuticals Co.,Ltd.
- GlaxoSmithKline
- Simcere Pharmaceutical Co., Ltd
- National Cancer Institute (NCI)
- Beijing Tiantan Hospital
- Harvard University
- Johns Hopkins University
- New York University
- Northwestern University
- University of Toronto
- Mayo Clinic
- Capital Medical University
- University of California, Los Angeles
- University of Cincinnati
- University of Copenhagen
- Department of Defense
- University of Alabama, Birmingham
- University of Paris
- The Children's Tumor Foundation
- Memorial Sloan-Kettering Cancer Center
Organization Involved with Phase 1 Indications (9)
Organization Involved with Other Experimental Indications (3)